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Irradiation has been increasingly recognized as an effective decontamination technique 
that ensures the chemical and organoleptic quality of medicinal and aromatic plants. 
The aim of the present study was to evaluate the effects of gamma irradiation in the 
phenolic compounds of Ginkgo biloba L. (infusion and methanol/water extract), widely 
used in traditional medicine and in dietary supplements. Twenty-five compounds were 
detected, eighteen of which were flavonoids, one phenolic acid, five terpene lactones 
and one unknown compound. Among the quantified phenolic compounds, flavonoids 
were the main group present, being two kaempferol derivatives the major compounds 
found: kaempferol-3-O-dirhamnosylglucoside and kaempferol-3-O-rutinoside. The 
irradiation with the highest dose (10 kGy) is sufficient to guarantee the product 
disinfestation and microbial decontamination, also contributing to an increase in the 
extractability of phenolic compounds, both in methanol/water and infusion preparations.  
 




The interest for natural antioxidants has been increasing over the years. Phenolic 
compounds comprise a very large group of biologically active molecules, being 
appreciated for their beneficial effects on health (physiologically active compounds with 
anti-allergic, anti-atherogenic, antimicrobial, antithrombotic, anti-inflammatory, 
antioxidant, cardioprotective and vasodilatory effects) (Mendel and Youdim, 2004; 
Balasundram et al., 2006; Martins et al., 2011). Their mechanism of action as 
antioxidants is considered essential regarding the reduction of the oxidation processes in 
the body, playing an important role in maintaining health, including protection of the 
cells and biomacromolecules and, therefore, intervening against certain human diseases 
(cancer, inflammatory diseases, neurological degeneration, heart disease, and many 
others) (Lan et al., 2007; Rawat et al., 2011; Acosta-Estrada et al., 2014). Thus, the 
most cited forms of intervention of antioxidant potential of phenolic compounds are 
their ability to scavenge reactive oxygen species and to chelate metal ions (Port's et al., 
2013). 
Plants are some of the most important sources of natural antioxidants including phenolic 
compounds (e.g., phenolic acids and flavonoids, phenolic diterpenes and tannins), 
which have been related with the bioactivity of several medicinal plants (Sati et al., 
2013). One of those plants that has been highly studied is Ginkgo biloba L., due to its 
use in traditional medicine, but also by professionals in the medical field in order to 
treat problems typically associated with aging, such as intermittent claudication, 
decreased mental vitality in old age (mental confusion, memory loss, dementia praecox, 
concentration problems), poor circulation and tinnitus (Diamond et al., 2000). The 
extracts from G. biloba, such as EGb761 in Tebonin®, are also used as alternative 
therapy against Alzheimer's disease (van Beek and Montoro, 2009; Parimoo et al., 
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2014). The products with this plant are commercially available in various forms: leaves 
for infusions preparation, standardized extracts, pills, capsules or oral solutions (Liu et 
al., 2014).  
The effectiveness of the therapeutic use of this plant leads to a strong demand from the 
pharmaceutical industry (Koch, 2005). However, due to the strict hygiene standards 
applied for raw materials to be incorporated into pharmaceuticals and/or dietary 
supplements, efficient decontamination methods are necessary, avoiding other 
alternatives that may leave chemical residues in the plant (Haleem et al., 2014).  
The use of irradiation has been increasingly accepted for decontamination and 
conservation, since it does not significantly affect (at specific doses) the organoleptic 
and physico-chemical properties of the irradiated matrices (Alothman et al., 2009; 
Kirkin et al., 2014), including G. biloba (Pereira et al., 2015). This method reduces 
reliance on chemical fumigants (ethylene oxide and methyl bromide), which have been 
pointed out as mutagens and carcinogens to humans, leave chemical residue on plants 
and destroy the ozone layer in the atmosphere (Migdal & Owczarczyk, 1998; 
Chmielewski & Migdal, 2005). 
Therefore, this study aims to evaluate if gamma irradiation (at doses of 1 and 10 kGy) 
improves the extraction of phenolic compounds using Ginkgo biloba (infusion and 
methanolic extract) as source material. 
 
2. Materials and methods 
2.1. Samples and samples irradiation 
Ginkgo biloba L. samples were supplied by Américo Duarte Paixão Lda., Alcanede 
(Portugal), imported from China, as dry leaves material. The botanical identification 
was confirmed by the biologist, Dr. Carlos Aguiar of the Escola Superior Agrária of the 
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Polytechnic Institute of Bragança (Trás-os-Montes, Portugal). The samples were 
divided into three groups: control (non-irradiated, 0 kGy), group 1 and group 2, where 1 
kGy and 10 kGy were, respectively, the predicted doses. 
The irradiation was performed in a Co-60 experimental chamber (Precisa 22, Graviner 
Manufacturing Company Ltd., UK) with total activity 177 TBq (4.78 kCi), in 
September 2013, and the estimated dose rate for the irradiation position was obtained 
with Fricke dosimeter. During irradiation process, the dose was estimated using Amber 
Perspex routine dosimeters (batch V, from Harwell Company, U.K.), following the 
procedure previously described by Pereira et al. (2015). The estimated doses, dose rates 
and dose uniformity ratios (Dmax/Dmin) were, respectively: 1.20 ± 0.07 kGy, 2.57 ± 0.15 
kGy h–1, 1.20 for sample 1 and 8.93 ± 0.14 kGy, 1.91 ± 0.03 kGy h–1, 1.02 for sample 2. 
For simplicity, in the text and tables we considered the values 0, 1 and 10 kGy, for the 
doses of non-irradiated and irradiated groups 1 and 2, respectively. 
After irradiation, the samples were reduced to powder and mixed to obtain 
homogenized samples for subsequent analysis. 
 
2.2. Standards and Reagents 
For irradiation: To estimate the dose and dose rate of irradiation a chemical solution 
sensitive to ionizing radiation, Fricke dosimeter, prepared in the lab following the 
standards (ASTM, 1992) and Amber Perspex dosimeters (batch V, from Harwell 
Company, UK) were used. The acid aqueous Fricke dosimeter solution was prepared 
using ferrous ammonium sulfate(II) hexahydrate, sodium chloride and sulfuric acid, all 
purchased from Panreac S.A. (Barcelona, Spain) with purity PA (proanalysis), and 
water treated in a Milli-Q water purification system (Millipore, model A10, USA). 
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For chemical analyses: HPLC-grade acetonitrile was obtained from Merck KgaA 
(Darmstadt, Germany). Formic acid was purchased from Prolabo (VWR International, 
Fontenay-sous-Bois, France). Phenolic standards were from Extrasynthèse (Genay, 
France). Water was treated in Milli-Q water purification system (TGI Pure Water 
Systems, Greenville, SC, USA). 
 
2.3. Phenolic compounds 
2.3.1. Extraction procedure 
Methanol/water extracts: each sample (1 g) was extracted with 30 mL of 
methanol/water 80:20 (v/v) at room temperature, 150 rpm, for 1 h. The extract was 
filtered through Whatman 4 paper. The residue was then re-extracted twice, with 
additional 30 mL portions of methanol/water 80:20 (v/v). The combined extracts were 
evaporated under reduced pressure (rotary evaporator Büchi R-210), until complete 
removal of methanol. The aqueous phase was lyophilized (FreeZone 4.5, Labconco, 
Kansas City, MO, USA) (Barros et al., 2013).  
Infusions preparation: each sample (1 g) was added to 200 mL of boiling distilled water 
and left to stand at room temperature for 5 min, and then filtered under reduced 
pressure; afterwards the obtained infusion was frozen and lyophilized (Barros et al., 
2013). 
Methanol/water extracts and lyophilized infusions were re-dissolved in 20% aqueous 
methanol and water, respectively, at 20 mg/mL and filtered through a 0.22 µm 
disposable LC filter disc for High Performance Liquid Chromatography (HPLC) 
analysis. 
 
2.3.2. Analysis of phenolic compounds 
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Phenolic compounds were determined by HPLC (Hewlett-Packard 1100, Agilent 
Technologies, Santa Clara, CA, USA) as previously described by the authors (Barros et 
al., 2013). Double online detection was carried out in a DAD using 280 nm and 370 nm 
as preferred wavelengths and in a mass spectrometer (API 3200 Qtrap, Applied 
Biosystems, Darmstadt, Germany) connected to the HPLC system via the DAD cell 
outlet. The phenolic compounds were characterized according to their UV and mass 
spectra and retention times, and comparison with authentic standards when available. 
The phenolic compounds were identified by comparing their retention time, UV–vis and 
mass spectra with those obtained from standard solutions, when available. Otherwise, 
peaks were tentatively identified comparing the obtained information with available 
data reported in the literature. For quantitative analysis, a calibration curve for each 
available phenolic standard was constructed based on the UV signal. For the identified 
phenolic compounds for which a commercial standard was not available, the 
quantification was performed through the calibration curve of other compounds from 
the same phenolic group. The results were expressed in mg/g of methanol/water extract 
and lyophilized infusion. 
 
2.4. Statistical analysis 
Three samples from each group were analysed and all the assays were carried out in 
triplicate. The results are expressed as mean values±standard deviation (SD). The 
results were analyzed using one-way analysis of variance (ANOVA) followed by 
Tukey’s HSD Test with α = 0.05. This treatment was carried out using SPSS v. 22.0 
program (IBM Corp.).  
 
3. Results and Discussion 
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3. Results and Discussion 
The chromatographic profile of non-irradiated and irradiated at 10 kGy G. biloba 
samples, obtained after methanol/water extraction, and recorded at 370 nm is shown in 
Figure 1; compound characteristics and tentative identities are presented in Table 1. 
Twenty-five compounds were detected, eighteen of which were flavonoids, one 
phenolic acid, five terpene lactones and one unknown compound.  
Protocatechuic acid (compound 3), myricetin-3-O-rutinoside (compound 11), quercetin-
3-O-rutinoside (compound 15), quercetin-3-O-glucoside (compound 17), kaempferol-3-
O-rutinoside (compound 19), isorhamnetin-3-O-rutinoside (compound 20) and 
isorhamnetin-3-O-glucoside (compound 22) were positively identified according to 
their retention, mass and UV-vis characteristics by comparison with commercial 
standards. All the compounds mentioned above, with the exception of protocatechuic 
acid were previously reported in leaves of G. biloba (Tang et al., 2001; Zhang et al., 
2007; Ding et al., 2008; Lin et al., 2008). 
Peaks 1, 2, 4-6 and 12 were associated to terpene trilactones. That type of compounds 
have low UV absorption and coexisting substances present in the complex matrix of G. 
biloba extracts make it difficult for their detection and quantification, using UV 
detection (Sloley et al., 2003; Mesbah et al., 2005). Nonetheless, they could be detected 
in the analysed extracts and tentatively identified based on their MS characteristics and 
comparison with data reported in the bibliography (Bedir et al., 2002; van Beek, 2002; 
Ding et al., 2008; Lin et al., 2008; van Beek and Montoro, 2009; Rossi et al., 2011; Liu 
et al., 2014); in particular, bilobalide (compound 4), ginkgolide A (compound 5), 
ginkgolide B (compound 6) and ginkgolide C derivative (compound 12). The latter 
compound should correspond to a derivative of ginkgolide C, since ginkgolide C would 
be expected to elute earlier than ginkgolide A and B (Ding et al., 2008; Lin et al., 2008; 
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van Beek & Montoro, 2009). No identification could be assigned to compound 1 
([M−H]- at m/z 453), although the major m/z fragment at 407 might point to it was a 
derivative of ginkgolide A. No conclusions could be drawn about the identity and nature 
of compound 2 ([M-H]- at m/z 449). Three compounds with the same pseudomolecular 
ion were also detected by Ding et al. (2008) in G. biloba supplements, which were 
assigned as unknown glycosyl flavonoids. However, the flavonoid nature of the 
compound was not clear in our samples, but the presence of MS2 fragments at m/z 179 
and 113 also observed in compounds 1 and 6 rather suggested that it could be a 
ginkgolide, which remained unknown.  
The rest of compounds showed UV and mass characteristics coherent with flavonol 
glycosides. Compounds 9, 19 and 23 ([M-H]- at m/z 593) presented characteristics that 
match a structure of kaempferol bearing deoxyhexosyl and hexosyl residues. Ding et al. 
(2008) also detected three compounds with the same mass in G. biloba supplements, all 
of them identified as kaempferol-O-rhamnosyl-glucoside. Zhang et al. (2007) and Lin et 
al. (2008) also found two compounds with similar characteristics in G. biloba leaves, 
one of them kaempferol-3-O-rutinoside (positively identified as peak 19 in our samples) 
and the other one as kaempferol-3-O-glucosyl-(1,2)-rhamnoside. This latter identity was 
assumed for peak 23 owing to its delayed elution in relation to peak 19, as reported by 
those authors. As no further information was available for compound 9 it was just 
assigned as a kaempferol-O-rhamnosyl-glucoside. Similar reasoning was applied for the 
identification of compounds 15 and 18 showing the same pseudomolecular ion [M-H]- 
at m/z 609, which were respectively identified as quercetin-3-O-rutinoside and 
quercetin-3-O-glucosyl-(1,2)-rhamnoside, as also reported Zhang et al. (2007) and Lin 
et al. (2008).  
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Compounds 7, 10 and 24 presented the same pseudomolecular ion [M-H]- at m/z 755. 
Their MS2 spectra pointed to they are derived from different aglycones, i.e., kaempferol 
(7) and quercetin (10 and 24). Different compounds with similar UV and mass 
characteristics were reported by Lin et al. (2008) and Ding et al. (2008) in G. biloba 
leaves and supplements. Compound 7 would correspond to a kaempferol derivative 
bearing one deoxyhexosyl and two hexosyl residues; the observation of a main MS2 
fragment at m/z 593 from the lost of the hexosyl residue suggested that this latter was 
located at a different position of the other two glycosyl moieties that could be 
constituting a disaccharide. Although no information about the actual nature and 
position of the sugar substituents can be obtained from the available data, based on the 
previous comments assumption and the identification made by Lin et al. (2008) the 
compound was tentatively assigned as kaempferol-3-O-rhamnosylhexoside-7-O-
glucoside. Characteristics of compound 10 were consistent with a quercetin derivative 
possessing two deoxyhexosyl and one hexosyl residues. The fact that only one MS2 
fragment was released corresponding to the aglycone (i.e., m/z at 301, quercetin) would 
suggest that the three sugars constituted a trisaccharide; based on this assumption the 
compound was tentatively identified as quercetin 3-O-2’’,6’’-dirhamnosylglucoside 
reported in G. biloba leaves by Lin et al. (2008). Compound 24 showed different UV 
and MS2 spectra than compound 10, presenting maximum wavelength at 316 nm and an 
additional minor MS2 fragment at m/z 609 (loss of 146 mu that may correspond to either 
a rhamnosyl or a p-coumaroyl moiety), due to its delayed retention time and previous 
identifications of similar compounds by Lin et al. (2008) and Ding et al. (2008), this 
compound was tentatively assigned as quercetin-3-O-p-coumaroyl-rhamnosylhexoside. 
Similar reasoning was applied for assigning compounds 13 and 25, both showing 
pseudomolecular ions [M-H]- at m/z 739, which were tentatively identified respectively 
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as kaempferol-3-O-dirhamnosylglucoside and kaempferol-3-O-p-coumaroyl-
rhamnosylhexoside,  as also proposed by Lin et al. (2008). 
Mass spectra characteristics of compounds 8 ([M-H]- at m/z 785) and 14 ([M-H]- at m/z 
769) were similar to those of compounds 7 and 13 respectively, but derived from an 
isorhamnetin aglycone as revealed by the MS2 fragment produced at m/z 315. Based on 
this observation and previous identifications by Lin et al. (2008), these compounds were 
respectively assigned as isorhamnetin-3-O-rhamnosylhexoside-7-O-glucoside and 
isorhamnetin-3-O-dirhamnosylglucoside. Compounds 16 ([M-H]- at m/z 639) and 21 
([M-H]- at m/z 447) were assigned as patuletin-3-O-rutinoside and quercetin-3-O-
rhamnoside, owing the identification of these compound in leaves from G. biloba by 
Lin et al. (2008) and the latter one also by Yao et al. (2013).  
Among the twenty-five compounds detected, compounds 1, 2, 4-6 and 12, associated to 
ginkgolides, were not quantified due their low UV absorption and possible interferences 
in the complex matrix of G. biloba extracts, as well as the unavailability of commercial 
gingkolide standards. Flavonoids were the main group present, being two kaempferol 
derivatives the majority compounds found (Table 2). Thus, kaempferol-3-O-
dirhamnosylglucoside (compound 13) was the most abundant compound in all the 
infusion preparations and in the methanol/water extract irradiated at 1 kGy, whereas 
kaempferol-3-O-rutinoside (compound 19) was the most abundant one in the control 
and irradiated at 10 kGy methanol/water extracts. Protocatechuic acid was the only 
phenolic acid identified and the quantities present were in the same range as the major 
flavonoids. 
This study intended to evaluate which irradiation dose would be the most efficient to 
improve the extractability of phenolic compounds in G. biloba samples (methanol/water 
extract and infusion oral solution). Infusions presented lower quantities than the 
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methanol/water extracts, due to the high temperatures applied to obtain these 
preparations that could destroy some thermal sensitive compounds, but also due to the 
lower extraction time. Both methanol/water and infusion preparation irradiated at a dose 
of 10 kGy gave the highest content in phenolic compounds. The sub-products formed 
during food irradiation depend on the food matrix and dose (Stewart, 2001). The 
degradation of some molecules during irradiation occurs by complex mechanisms. 
Although it is considered that some bonds can be broken resulting in smaller molecules 
(Stewart, 2001), the use of high irradiation doses might also lead to higher compound 
extractability. This could explain the higher values of phenolic compounds 
concentration observed for the doses of 10 kGy compared with those found in non-
irradiated and 1 kGy irradiated samples. A small decrease in the phenolic compounds 
content was observed for the dose of 1 kGy in the methanol/water extract, when 
compared with non-irradiated samples. Low doses up to 1 kGy are used for preservation 
of fresh samples (Molins, 2001), which are more sensitive than dried food, indicating 
that at this doses there are no effect or only slight changes in food main characteristics. 
To our knowledge, this is the first report that describes the phenolic composition in 
irradiated samples of G. biloba using two different doses. The dose of 10 kGy is enough 
to guarantee product disinfestation and microbial decontamination (Molins, 2001), 
contributing also for an increase in the phenolic compounds extractability, both for 
methanol/water and infusion preparations. The use of irradiation to improve bioactive 
properties was also suggested by other authors as a result of an increase in the levels of 
phenolic compounds in the extracts obtained from cooked and derived plant products 
(Zhu et al., 2010; Aouidi et al., 2011; Lee et al., 2013; Wanyo et al., 2014). 
Nevertheless, further research is needed to understand all the mechanisms involved in 
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data and compound identification in 
G. biloba samples. 
 
Compound Rt (min) 
λmax 
 (nm) 





1 5.7 260,294,350 453 407(100),245(3),179(7),161(3),113(5) Ginkgolide A derivative 
2 6.1 358 449 403(16),269(4),205(8),179(5),113(4) Unknown ginkgolide 
3 6.2 262sh294 153 109(100) Protocatechuic acid 
4 6.8 252,356 325 163(100),119(87) Bilobalide  
5 7.1 274 407 245(100) Ginkgolide A 
6 9.3 282sh336 423 221(15),179(13),161(22),131(21),113(32) Ginkgolide B 
7 9.6 348 755 593(100),285(22) Kaempferol-3-O-rhamnosylhexoside-7-O-glucoside 
8 11.3 358 785 623(100),315(17) Isorhamnetin-3-O-rhamnosylhexoside-7-O-glucoside 
9 14.0 348 593 447(23),285(58) Kaempferol-O-rhamnosyl-glucoside 
10 15.0 354 755 301(100) Quercetin 3-O-2’’,6’’-dirhamnosylglucoside  
11 15.1 350 625 317(100) Myricetin-3-O-rutinoside 
12 16.5 318 439*1 411(18),383(93),365(12),322(26),304(7),277(7),259(8) Ginkgolide C derivative 
13 17.0 348 739 285(100) Kaempferol-3-O-dirhamnosylglucoside  
14 17.4 356 769 315(100) Isorhamnetin-3-O-dirhamnosylglucoside  
15 18.3 356 609 301(100) Quercetin-3-O-rutinoside 
16 19.1 360 639 331(100) Patuletin-3-O-rutinoside 
17 19.7 358 463 301(100) Quercetin-3-O-glucoside 
18 21.1 352 609 301(100) Quercetin-3-O-glucosyl-(1,2)-rhamnoside 
19 21.7 348 593 285(100) Kaempferol-3-O-rutinoside   
20 22.6 356 623 315(100) Isorhamnetin-3-O-rutinoside 
19 
 
*1 879 [2M-H]-  
21 23.1 352 447 301(100) Quercetin-3-O-rhamnoside 
22 23.8 350 477 315(100) Isorhamnetin-3-O-glucoside 
23 25.1 348 593 285(100) Kaempferol-3-O-glucosyl-(1,2)-rhamnoside 
24 28.1 268,316 755 609(46),301(21) Quercetin-3-O-p-coumaroyl-rhamnosylhexoside 




Table 2. Quantification of the phenolic compounds (mg/g of extract/lyophilized infusion) identified in methanol/water extracts and infusions of 
G. biloba non-irradiated and irradiated samples. 
 
Compounds Methanol/water extracts Infusions  
0 kGy 1 kGy 10 kGy  0 kGy 1 kGy 10 kGy 
Ginkgolide A derivative nq nq nq nq nq nq 
Unknown ginkgolide nq nq nq nq nq nq 
Protocatechuic acid 1.39 ± 0.08 1.22 ± 0.04 4.49 ± 0.05 0.43 ± 0.04 0.38 ± 0.01 1.95 ± 0.05  
Bilobalide  nq nq nq nq nq nq 
Ginkgolide A nq nq nq nq nq nq 
Ginkgolide B nq nq nq nq nq nq 
Kaempferol-3-O-rhamnosylhexoside-7-O-glucoside 0.34 ± 0.02 0.49 ± 0.01 1.16 ± 0.06 0.24 ± 0.02 0.25 ± 0.01 0.34 ± 0.05 
Isorhamnetin-3-O-rhamnosylhexoside-7-O-glucoside 0.32 ± 0.04 0.45 ± 0.04 1.09 ± 0.14 0.22 ± 0.02 0.24 ± 0.02 0.35 ± 0.05 
Kaempferol-O-rhamnosyl-glucoside 0.12 ± 0.02 0.16 ± 0.01 0.53 ± 0.11 0.03 ± 0.01 0.04 ± 0.00 0.11 ± 0.02 
Quercetin 3-O-2’’,6’’-dirhamnosylglucoside  0.55 ± 0.01 0.66± 0.04 1.67 ± 0.07 0.17 ± 0.01 0.19 ± 0.01 0.56 ± 0.03 
Myricetin-3-O-rutinoside 0.11 ± 0.01 0.07 ± 0.01 0.59 ± 0.08 nd nd 0.12 ± 0.03 
Ginkgolide C derivative nq nq nq nd nq nq 
Kaempferol-3-O-dirhamnosylglucoside  1.26 ± 0.01 1.48 ± 0.02 3.57 ± 0.03 0.44 ± 0.02 0.40 ± 0.02 1.29 ± 0.01 
Isorhamnetin-3-O-dirhamnosylglucoside  0.42 ± 0.01 0.51 ± 0.03 1.30 ± 0.02 0.16 ± 0.01 0.15 ± 0.01 0.45 ± 0.01 
Quercetin-3-O-rutinoside 0.84 ± 0.06 0.34 ± 0.02 2.74 ± 0.07 tr 0.07 ± 0.01 0.74 ± 0.03 
Patuletin-3-O-rutinoside 0.52 ± 0.01 0.25 ± 0.01 1.89 ± 0.04 tr 0.04 ± 0.00 0.51 ± 0.03 
Quercetin-3-O-glucoside 0.08 ± 0.01 tr 0.56 ± 0.05 nd nd 0.05 ± 0.02 
Quercetin-3-O-glucosyl-(1,2)-rhamnoside 0.20 ± 0.02 0.04 ± 0.01 0.78 ± 0.06 nd tr 0.17 ± 0.01 
Kaempferol-3-O-rutinoside   1.38 ± 0.04 0.57 ± 0.03 4.21 ± 0.02 0.02 ± 0.00 0.16 ± 0.02 1.15 ± 0.04 
Isorhamnetin-3-O-rutinoside 1.06 ± 0.02 0.49 ± 0.03 3.05 ± 0.06 0.03 ± 0.00 0.16 ± 0.01 0.95 ± 0.01 
Quercetin-3-O-rhamnoside 0.16 ± 0.01 0.09 ± 0.01 0.67 ± 0.05 nd tr 0.17 ± 0.02 
Isorhamnetin-3-O-glucoside 0.15 ± 0.04  0.12 ± 0.01 0.46 ± 0.05 nd 0.04 ± 0.00 0.16 ± 0.01 
Kaempferol-3-O-glucosyl-(1,2)-rhamnoside 0.49 ± 0.02 0.15 ± 0.03 1.81 ± 0.15 0.02 ± 0.00 0.02 ± 0.00 0.38 ± 0.01 
Quercetin-3-O-p-coumaroyl-rhamnosylhexoside 0.06 ± 0.01 0.04 ± 0.00 1.30 ± 0.08 tr tr 0.10 ± 0.02 
21 
 
Kaempferol-3-O-p-coumaroyl-rhamnosylhexoside 0.11 ± 0.01 0.09 ± 0.01 1.83 ± 0.04 0.02 ± 0.00 0.01 ± 0.00 0.15 ± 0.01 
Total phenolic acids  1.40 ± 0.08b 1.22 ± 0.04c 4.49 ± 0.05a 0.43 ± 0.04b 0.38 ± 0.01b 1.95 ± 0.05a 
Total flavonoids 8.16 ± 0.04b 6.00 ± 0.18c 29.20 ± 0.74a 1.35 ± 0.01c 1.75 ± 0.06b 7.76 ± 0.16a 
Total phenolic compounds 9.56 ± 0.06b 7.22 ± 0.22c 33.69 ± 0.69a 1.78 ± 0.06c 2.13 ± 0.04b 9.70 ± 0.11a 





































































































































Figure 1. Chromatographic profile of non-irradiated methanol/water (A), irradiated at 10 kGy methanol/water (B), non-irradiated infusion (C) 
and irradiated at 10 kGy infusion (D) of G. biloba samples, recorded at 370 nm. 
